Pharmaceutical giants Novo Nordisk and Eli Lilly have driven valuations to new heights, but recent proposals to slash drug prices are adding volatility to the market
Why should you use it for pigmentation & melasma
Glucose-dependent insulinotropic polypeptide (GIP) also influences fat metabolism and helps the body process nutrients more efficiently
But if you do experience it, its important to know whats causing it so you can get some relief
Patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should be counselled about this risk Patient safety advice for those using GLP-1 receptor agonists includes: Report persistent nausea, vomiting, or abdominal pain to your GP promptly Stop treatment and seek urgent medical care if you develop severe, persistent abdominal pain that may suggest pancreatitis Maintain adequate hydration, especially during initial treatment and if experiencing vomiting or diarrhoea Monitor for signs of gallbladder problems (sustained upper right abdominal pain, fever, jaundice) Patients with diabetes should monitor blood glucose levels closely, particularly when starting treatment or adjusting doses Inform healthcare providers of all medications to assess interaction risks Report suspected side effects via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app Pregnant women or those planning pregnancy should not use GLP-1 receptor agonists
At 10 mg/ml, the sweet spot for most users falls between 2.5 mg (0.25 ml) and 10 mg (1.00 ml)
